Spinal Muscular Atrophies are neurodegenerative disorders that are common in our region. In fact, they are the second most common autosomal recessive disorder. The incidence is 1 per 10,000. Genetically, caused by defects in the Survival Motor Neuron (SMN) gene on chromosome 5q. There are two types of SMN, SMN1 and SMN2. 95% of SMA patients have abnormality in SMN1; whereas SMN2 acts as a phenotypic modifier. The search for a cure has been a long journey. Promising therapeutic options have become available. Despite this progress, management of children/adults with SMA faces some big challenges. The success of the management pathway relies heavily on “multidisciplinary” input and the experience of care providers.


Article metrics loading...

Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error